Real-world evidence data (RWED) of financial toxicity (FT) in cancer patients (pts) receiving immunotherapy drugs (IOT)

被引:1
|
作者
Vorobiof, D. A. [1 ]
Hasid, L. [1 ]
Litvin, A. [1 ]
Deutsch, I. [1 ]
Malki, E. [1 ]
机构
[1] Belong Life Ltd, Caesarea, Israel
关键词
D O I
10.1016/j.annonc.2020.08.1921
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1612P
引用
收藏
页码:S969 / S969
页数:1
相关论文
共 50 条
  • [41] The risk of uveitis in patients with JIA receiving etanercept: the challenges of analysing real-world data
    Davies, Rebecca
    De Cock, Diederik
    Kearsley-Fleet, Lianne
    Southwood, Taunton
    Baildam, Eileen
    Beresford, Michael W.
    Foster, Helen E.
    Thomson, Wendy
    Ramanan, Athimalaipet, V
    Hyrich, Kimme L.
    RHEUMATOLOGY, 2020, 59 (06) : 1391 - 1397
  • [42] Real-world data (RWD) on tumor response (rwTR) in advanced non-small cell lung cancer (aNSCLC) patients receiving cancer immunotherapy and targeted therapies.
    Lu, Michael
    Sadetsky, Natalia
    Lambert, Peter
    Whipple, Sam
    Taylor, Michael Dennis
    Riehl, Todd
    Riely, Gregory J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [43] Modeling tumor size dynamics based on real-world electronic health records and image data in advanced melanoma patients receiving immunotherapy
    Courlet, Perrine
    Abler, Daniel
    Guidi, Monia
    Girard, Pascal
    Amato, Federico
    Violi, Naik Vietti
    Dietz, Matthieu
    Guignard, Nicolas
    Wicky, Alexandre
    Latifyan, Sofiya
    De Micheli, Rita
    Jreige, Mario
    Dromain, Clarisse
    Csajka, Chantal
    Prior, John O.
    Venkatakrishnan, Karthik
    Michielin, Olivier
    Cuendet, Michel A.
    Terranova, Nadia
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2023, 12 (08): : 1170 - 1181
  • [44] Real-world data of anamorelin in advanced gastrointestinal cancer patients with cancer cachexia
    Nishimura, Ari
    Hamauchi, Satoshi
    Notsu, Akifumi
    Fushiki, Kunihiro
    Oshima, Kotoe
    Tsushima, Takahiro
    Kawakami, Takeshi
    Todaka, Akiko
    Yokota, Tomoya
    Yasui, Hirofumi
    Onozawa, Yusuke
    Yamazaki, Kentaro
    BMC PALLIATIVE CARE, 2024, 23 (01):
  • [45] Adjuvant immunotherapy in patients with resected esophageal and gastroesophageal junction cancer: Real-world evidence from Nova Scotia.
    Sheridan, Margaret
    Snow, Stephanie Leann
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16047 - E16047
  • [46] Age-related real-world outcomes for patients (pts) with metastatic colorectal cancer (mCRC).
    Curtis, Melissa
    Nussbaum, Nathan Coleman
    Hamrick, Harvey J.
    Bennette, Caroline Savage
    Meropol, Neal J.
    Miksad, Rebecca A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [47] Role of Real-World Data in Assessing Cardiac Toxicity After Lung Cancer Radiotherapy
    Abravan, Azadeh
    Price, Gareth
    Banfill, Kathryn
    Marchant, Tom
    Craddock, Matthew
    Wood, Joe
    Aznar, Marianne C.
    McWilliam, Alan
    van Herk, Marcel
    Faivre-Finn, Corinne
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [48] Immunotherapy-based treatment in elderly cancer patients: A real-world multicenter study
    He, M.
    Shen, P.
    Xu, G.
    Xu, L.
    Chen, J.
    Ding, J.
    Chai, K.
    ANNALS OF ONCOLOGY, 2023, 34 : S1126 - S1126
  • [49] Real-world treatment outcomes among patients with metastatic pancreatic cancer in Japan: The Tokushukai real-world data project
    Shimoyama, Rai
    Imamura, Yoshinori
    Uryu, Kiyoaki
    Mase, Takahiro
    Fujimura, Yoshiaki
    Hayashi, Maki
    Ohtaki, Megu
    Ohtani, Keiko
    Shinozaki, Nobuaki
    Minami, Hironobu
    MOLECULAR AND CLINICAL ONCOLOGY, 2023, 19 (06)
  • [50] Cancer Risk in Patients with Gaucher Disease Using Real-World Data
    Revel-Vilk, Shoshana
    Zimran, Ari
    Istaiti, Majdolen
    Manor, Orly
    Shalev, Varda
    Azani, Litat
    Chodick, Gabriel
    Paltiel, Ora
    BLOOD, 2023, 142